Authors:
KEMAHLI S
ALHENCGELAS M
GANDRILLE S
AIACH M
AKAR N
CIN S
Citation: S. Kemahli et al., HOMOZYGOUS PROTEIN-C DEFICIENCY WITH A DOUBLE VARIANT HIS-202 TO TYR AND ALA-346 TO THR, Blood coagulation & fibrinolysis, 9(4), 1998, pp. 351-354
Authors:
SCARABIN PY
ALHENCGELAS M
PLUBUREAU G
TAISNE P
AGHER R
AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3071-3078
Authors:
LECAMDUCHEZ V
GANDRILLE S
ALHENCGELAS M
EMMERICH J
BORG JY
AIACH M
Citation: V. Lecamduchez et al., ADDITIONAL GENETIC RISK-FACTORS FOR THROMBOSIS IN 21 FAMILIES CARRYING THE FACTOR-V ARG-506 TO GLN MUTATION, Thrombosis and haemostasis, 1997, pp. 671-671
Authors:
SCARABIN PY
ALHENCGELAS M
PLUBUREAU G
TAISNE P
AGHER R
AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/, Thrombosis and haemostasis, 1997, pp. 788-788
Authors:
KEMAHLI S
GANDRILLE S
ALHENCGELAS M
AIACH M
CIN S
Citation: S. Kemahli et al., HOMOZYGOUS PROTEIN-C DEFICIENCY WITH A DOUBLE VARIANT HIS-202 TO TYR AND ALA-346 TO THR, Thrombosis and haemostasis, 1997, pp. 1690-1690
Authors:
EMMERICH J
ALHENCGELAS M
AILLAUD MF
JUHANVAGUE I
JUDE B
GARCIN JM
DREYFUS M
DEMOERLOOSE P
LEQUERREC A
PRIOLLET P
BERRUYER M
VALLANTIN X
WOLF M
AIACH M
FIESSINGER JN
Citation: J. Emmerich et al., CLINICAL-FEATURES IN 36 PATIENTS HOMOZYGOUS FOR THE ARG-506-]GLN-FACTOR-V MUTATION, Thrombosis and haemostasis, 77(4), 1997, pp. 620-623
Authors:
GARCIN JM
PLOTTON N
COLLET JP
ALHENCGELAS M
EMMERICH J
CHANUDET X
LARROQUE P
Citation: Jm. Garcin et al., ACTIVATED PROTEIN-C RESISTANCE AND Q506 MUTATION OF FACTOR-V IN VENOUS THROMBOEMBOLISM, La Semaine des hopitaux de Paris, 73(25-26), 1997, pp. 793-799
Authors:
ALHENCGELAS M
LECAMDUCHEZ V
EMMERICH J
FREBOURG T
FIESSINGER JN
BORG JY
AIACH M
Citation: M. Alhencgelas et al., THE A20210-ALLELE OF THE PROTHROMBIN GENE IS NOT FREQUENTLY ASSOCIATED WITH THE FACTOR-V-ARG-506-TO-GLN-MUTATION IN THROMBOPHILIC FAMILIES, Blood, 90(4), 1997, pp. 1711-1711
Authors:
EMMERICH J
ALHENCGELAS M
AIACH M
FIESSINGER JN
Citation: J. Emmerich et al., RESISTANCE TO ACTIVATED PROTEIN-C - ROLE IN VENOUS AND ARTERIAL THROMBOSIS, Biomedicine & pharmacotherapy, 50(6-7), 1996, pp. 254-260
Authors:
ALHENCGELAS M
AILLAUD MF
BONVARLET MN
DUPUY G
JUHANVAGUE I
AIACH M
Citation: M. Alhencgelas et al., SPECIFICITY OF AN ASSAY BASED AN A FACTOR V-DEPLETED PLASMA IN PATIENTS CARRYING THE ARG-506 GLN MUTATION, Thrombosis and haemostasis, 75(6), 1996, pp. 976-977
Authors:
ESCOFFREBARBE M
ALHENCGELAS M
AIACH M
EMMERICH J
Citation: M. Escoffrebarbe et al., ABSENCE OF LENGTH POLYMORPHISM WITHIN THE 31 TANDEM REPEATS OF THE B-DOMAIN OF FACTOR-V, Thrombosis and haemostasis, 75(5), 1996, pp. 862-863
Authors:
ALESSI MC
AILLAUD MF
PAUT O
ROQUELAURE B
ALHENCGELAS M
PELLISSIER MC
GHANEN N
JUHANVAGUE I
Citation: Mc. Alessi et al., PURPURA FULMINANS IN A PATIENT HOMOZYGOUS FOR A MUTATION IN THE PROTEIN-C GENE - PRENATAL-DIAGNOSIS IN A SUBSEQUENT PREGNANCY, Thrombosis and haemostasis, 75(3), 1996, pp. 525-526
Authors:
BORGEL D
DUCHEMIN J
ALHENCGELAS M
MATHERON C
AIACH M
GANDRILLE S
Citation: D. Borgel et al., MOLECULAR-BASIS FOR PROTEIN-S HEREDITARY-DEFICIENCY - GENETIC-DEFECTSOBSERVED IN 118 PATIENTS WITH TYPE-I AND TYPE IIA DEFICIENCIES, The Journal of laboratory and clinical medicine, 128(2), 1996, pp. 218-227
Authors:
TRILLOT N
PREUDHOMME C
ALHENCGELAS M
GAVERIAUX V
BAUTERS A
GANDRILLE S
AIACH M
JUDE B
Citation: N. Trillot et al., THERMOLABILE METHYLENE TETRA HYDRO FOLATE REDUCTASE (MTHFR) DOES NOT MODIFY THE RISK FOR VENOUS THROMBOEMBOLISM IN SUBJECTS WITH HETEROZYGOUS FACTOR-V LEIDEN, Blood, 88(10), 1996, pp. 1126-1126
Authors:
EMMERICH J
ALHENCGELAS M
ALACH M
FLESSINGER JN
Citation: J. Emmerich et al., ACTIVATED PROTEIN-C RESISTANCE - ROLE IN VENOUS AND ARTERIAL THROMBOSIS, Archives des maladies du coeur et des vaisseaux, 89(6), 1996, pp. 741-745
Citation: S. Gandrille et al., A RAPID SCREENING METHOD FOR THE FACTOR-V ARG506-]GLN MUTATION, Blood coagulation & fibrinolysis, 6(3), 1995, pp. 245-248
Authors:
ALHENCGELAS M
EMMERICH J
GANDRILLE S
AUBRY ML
BENAILY N
FIESSINGER JN
AIACH M
Citation: M. Alhencgelas et al., PROTEIN-C INFUSION IN A PATIENT WITH INHERITED PROTEIN-C DEFICIENCY CAUSED BY 2 MISSENSE MUTATIONS - ARG 178 TO GLN AND ARG-1 TO HIS, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 35-41
Authors:
LEVOIR D
AUBERTIN JM
ALHENCGELAS M
BLOCH F
BECHEUR H
PETITE JP
Citation: D. Levoir et al., A NEW HEREDITARY CAUSE OF PORTAL-VEIN THR OMBOSIS - ABNORMAL RESISTANCE, TO ACTIVATED PROTEIN-C BY ARG506-]GIN MUTATION IN THE GENE FOR FACTOR-V, Gastroenterologie clinique et biologique, 19(8-9), 1995, pp. 729-731
Authors:
GREENGARD JS
ALHENCGELAS M
GANDRILLE S
EMMERICH J
AIACH M
GRIFFIN JH
Citation: Js. Greengard et al., PSEUDO-HOMOZYGOUS ACTIVATED PROTEIN-C RESISTANCE DUE TO COINHERITANCEOF HETEROZYGOUS FACTOR V-R506Q AND TYPE-I FACTOR-V DEFICIENCY ASSOCIATED WITH THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1361-1361